World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Prof
Tel Aviv University
Showing your local timezone
Schedule
Thursday, May 6, 2021
4:00 PM Asia/Tokyo
Seminar location
No geocoded details are available for this content yet.
Recording provided by the organiser.
Format
Recorded Seminar
Recording
Available
Host
Consciousness Club Tokyo
Seminar location
No geocoded details are available for this content yet.
Over the last fifteen years, Simona Ginsburg and I developed an evolutionary approach for studying basic consciousness, suggesting that the evolution of learning drove the evolutionary transition to from non-conscious to conscious animals. I present the rationale underlying this thesis, which has led to the identification of a capacity that we call the evolutionary transition marker, which, when we find evidence of it, we have evidence that the major evolutionary transition in which we are interested has gone to completion. I then put forward our proposal that the evolutionary marker of basic consciousness is a complex form of associative learning that we call unlimited associative learning (UAL), and that the evolution of this capacity drove the transition to consciousness. I discuss the implications of this thesis for questions pertaining to the neural dynamics that constitute conscious, to its taxonomic distribution and to the ecological context in which it first emerged. I end by pointing to some of the ways in which the relationship between UAL and consciousness can be experimentally tested in humans and in non-human animals.
Eva Jablonka
Prof
Tel Aviv University
Contact & Resources
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe